These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12434475)

  • 1. Immune mechanisms in uveitis. What can be learned from in vivo imaging?
    Becker MD; Dullforce PA; Martin TM; Smith JR; Planck SR; Rosenbaum JT
    Ophthalmol Clin North Am; 2002 Sep; 15(3):259-70. PubMed ID: 12434475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraocular in vivo imaging of activated T-lymphocytes expressing green-fluorescent protein after stimulation with endotoxin.
    Becker MD; Crespo S; Martin TM; Planck SR; Naramura M; Rosenbaum JT
    Graefes Arch Clin Exp Ophthalmol; 2001 Aug; 239(8):609-12. PubMed ID: 11585318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invariant NKT cells regulate experimental autoimmune uveitis through inhibition of Th17 differentiation.
    Oh K; Byoun OJ; Ham DI; Kim YS; Lee DS
    Eur J Immunol; 2011 Feb; 41(2):392-402. PubMed ID: 21268009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN-gamma-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response.
    Jones LS; Rizzo LV; Agarwal RK; Tarrant TK; Chan CC; Wiggert B; Caspi RR
    J Immunol; 1997 Jun; 158(12):5997-6005. PubMed ID: 9190954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of experimental ocular inflammation on ocular immune privilege.
    Ohta K; Wiggert B; Taylor AW; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2010-8. PubMed ID: 10440255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tracking T lymphocytes proliferation with vital dye CFSE in experimental autoimmune uveitis].
    Lei S; Mao YQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Nov; 40(6):1127-9. PubMed ID: 20067135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uveitogenicity is associated with a Th1-like lymphokine profile: cytokine-dependent modulation of early and committed effector T cells in experimental autoimmune uveitis.
    Xu H; Rizzo LV; Silver PB; Caspi RR
    Cell Immunol; 1997 May; 178(1):69-78. PubMed ID: 9184700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTLA4-Ig suppresses development of experimental autoimmune uveitis in the induction and effector phases: Comparison with blockade of interleukin-6.
    Iwahashi C; Fujimoto M; Nomura S; Serada S; Nakai K; Ohguro N; Nishida K; Naka T
    Exp Eye Res; 2015 Nov; 140():53-64. PubMed ID: 26297802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-18 not required for IRBP peptide-induced EAU: studies in gene-deficient mice.
    Jiang HR; Wei X; Niedbala W; Lumsden L; Liew FY; Forrester JV
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):177-82. PubMed ID: 11133864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of in vivo regulatory properties of T cells activated in vitro by TGFbeta2-treated antigen presenting cells.
    Kezuka T; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1410-21. PubMed ID: 10798657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of Th1 and Th2 cells in lymph nodes and spleens of mice during experimental autoimmune uveoretinitis.
    Takeuchi M; Yokoi H; Tsukahara R; Sakai J; Usui M
    Jpn J Ophthalmol; 2001; 45(5):463-9. PubMed ID: 11583666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen-specific inhibition of experimental autoimmune uveoretinitis by bone marrow-derived immature dendritic cells.
    Jiang HR; Muckersie E; Robertson M; Forrester JV
    Invest Ophthalmol Vis Sci; 2003 Apr; 44(4):1598-607. PubMed ID: 12657598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of IL-17+ interphotoreceptor retinoid-binding protein-specific T cells in experimental autoimmune uveitis.
    Peng Y; Han G; Shao H; Wang Y; Kaplan HJ; Sun D
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4153-61. PubMed ID: 17724201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of T cells in autoimmune uveitis.
    Becker MD; Adamus G; Davey MP; Rosenbaum JT
    Ocul Immunol Inflamm; 2000 Jun; 8(2):93-100. PubMed ID: 10980681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of IL-35 by Bregs is mediated through binding of BATF-IRF-4-IRF-8 complex to il12a and ebi3 promoter elements.
    Yu CR; Choi JK; Uche AN; Egwuagu CE
    J Leukoc Biol; 2018 Dec; 104(6):1147-1157. PubMed ID: 30117603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of invariant NKT cells ameliorates experimental ocular autoimmunity by a mechanism involving innate IFN-gamma production and dampening of the adaptive Th1 and Th17 responses.
    Grajewski RS; Hansen AM; Agarwal RK; Kronenberg M; Sidobre S; Su SB; Silver PB; Tsuji M; Franck RW; Lawton AP; Chan CC; Caspi RR
    J Immunol; 2008 Oct; 181(7):4791-7. PubMed ID: 18802082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel CD28 antagonist mPEG PV1-Fab' mitigates experimental autoimmune uveitis by suppressing CD4+ T lymphocyte activation and IFN-γ production.
    Papotto PH; Marengo EB; Sardinha LR; Carvalho KI; de Carvalho AE; Castillo-Mendez S; Jank CC; Vanhove B; Goldberg AC; Rizzo LV
    PLoS One; 2017; 12(3):e0171822. PubMed ID: 28248972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intraocular inflammation and homeostasis of the eye].
    Mochizuki M
    Nippon Ganka Gakkai Zasshi; 2009 Mar; 113(3):344-77; discussion 378. PubMed ID: 19348183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tgf-beta inhibits activation and uveitogenicity of primary but not of fully polarized retinal antigen-specific memory-effector T cells.
    Xu H; Silver PB; Tarrant TK; Chan CC; Caspi RR
    Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4805-12. PubMed ID: 14578402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
    Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.